hydroxyzine and tirzepatide FDA Approves Tirzepatide, A Potential Blockbuster Drug for Type 2 Diabetes Weight Loss Drugs: America's Latest

Conflict of interest BG has served as a consultant for AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Merck (MSD) and Novartis as manufacturers of DPP-4 inhibitors and has received honoraria from these companies for lectures

Some doctors also suggest using a backup birth control method, such as condoms, during the first four weeks of starting tirzepatide

Tirzepatide: Clinical Results Weight Loss : Tirzepatide has shown even more impressive results

doi:10.1111/dme.15005 9

Some patients lose even more, while others lose slightly lessindividual results vary based on starting weight, adherence, lifestyle factors, and metabolism

STATs coverage of chronic health issues is supported by a grant from Bloomberg Philanthropies